Title : The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients.

Pub. Date : 2008 Jul

PMID : 18358555






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients. Metformin serpin family E member 1 Homo sapiens
2 After metformin addition, there was a significant decrement in BMI, waist circumference, fat percentage, fasting and postprandial plasma glucose, hemoglobin A1C, plasminogen activator inhibitor-1 (PAI-1), vascular endothelial growth factor (VEGF) and increment in beta cell reserve values of the patients. Metformin serpin family E member 1 Homo sapiens
3 After metformin addition, there was a significant decrement in BMI, waist circumference, fat percentage, fasting and postprandial plasma glucose, hemoglobin A1C, plasminogen activator inhibitor-1 (PAI-1), vascular endothelial growth factor (VEGF) and increment in beta cell reserve values of the patients. Metformin serpin family E member 1 Homo sapiens
4 Our results indicated that, metformin addition had beneficial effect on VEGF and PAI-1 levels in obese type 2 diabetic patients under MNT+REP, independent from its" favourable effects on BMI and glycemic control. Metformin serpin family E member 1 Homo sapiens